Janice Jones

Malcolm Bates is a partner in Goodwin’s Technology and Life Sciences groups based in Cambridge and London. He specialises in the commercialisation of intellectual property rights with particular expertise in life sciences. Mr. Bates advises on transactions, including licences, collaborations, distribution, manufacturing, outsourcing and R&D projects, as well as regulatory matters, contract and patent disputes, fundraisings, M&A transactions and IPOsPrior to joining Goodwin, he w...

Peter Coulton is a top attorney recognized by Best Lawyers in the practice area(s) of Banking and Finance Law. Peter, who practices law in London, United Kingdom, has been recognized since 2025. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Peter is held by other top lawyers in the same geographic and legal practice area.

Matthew James Priday is a Co-Chair of the GT London Real Estate Practice. Matthew focuses his practice on commercial real estate and has wide-ranging experience in investments sales and purchases, lettings and development projects. Matthew advises property industry clients across the real estate, retail and financial institutions sectors.

Jane Rogers is a partner in Ropes & Gray’s finance group in London, a member of the firm’s policy committee and a former co-head of the firm’s global finance practice. She focuses on private equity and debt financing transactions and was previously based in the Boston office before relocating to London in 2010.Jane regularly represents corporations and private equity funds in a variety of financing transactions, including high yield debt offerings, syndicated credit faci...

Morag Peberdy is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Morag, who practices law in London, United Kingdom, has been recognized since 2017. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Morag is held by other top lawyers in the same geographic and legal practice area.

Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences grou...

Aymen Mahmoud is the co-head of the London Finance, Restructuring and Special Situations Group. He focuses his practice on complex debt financing transactions for private equity funds and their portfolio companies, hedge funds, corporate borrowers and issuers and other financial institutions including banks, direct lenders, family offices and other alternative sophisticated capital. His experience includes acting in respect of direct lending, leveraged buyouts, domestic and cross-border syndi...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Marian heads the UK insurance and disputes practices working closely with the firm’s established trade and export finance team, and U.S.-based disputes team, offering advice on insurance, risk management and commercial dispute resolution.With over 20 years' experience, Marian advises banks, insurance brokers, investment funds, government agencies and corporates on commercial insurance arrangements which support structured trade, commodity and pre-export financing as well as corporate fi...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...